By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Discovery Laboratories, Inc. 

2600 Kelly Road

Warrington  Pennsylvania  18976  U.S.A.
Phone: 215-488-9300 Fax: 215-488-9301


SEARCH JOBS


Industry
Pharmaceutical






Company News
Discovery Laboratories (DSCO) Receives $1.0 Million Under An SBIR Grant In Continuing Support Of The Development Of Aerosolized KL4 Surfactant To Address Radiation-Induced Lung Injury 7/31/2015 9:35:26 AM
Discovery Laboratories (DSCO) Announces Completion of $40.25 Million Public Offering 7/23/2015 10:20:03 AM
Discovery Laboratories (DSCO) Announces Proposed Public Offering Of Common Stock, Warrants And Pre-Funded Warrants 7/17/2015 6:51:40 AM
Discovery Laboratories (DSCO) Receives Nasdaq Notification Related To Minimum Bid Price 7/1/2015 6:38:47 AM
Discovery Laboratories (DSCO) Announces Enrollment Of First Patient In AEROSURF Phase 2a Dose Expansion Trial 5/20/2015 6:31:03 AM
Discovery Laboratories (DSCO) Announces Results Of Phase 2a Clinical Trial Of AEROSURF 5/14/2015 6:21:11 AM
Discovery Laboratories (DSCO) To Announce Results From AEROSURF Phase 2a Clinical Trial 5/13/2015 10:17:29 AM
Discovery Laboratories (DSCO) Reports First Quarter 2015 Financial Results 5/8/2015 7:29:33 AM
Discovery Laboratories (DSCO) Ceasing Production of Lead Drug Surfaxin, Chops 50% Employees 4/16/2015 12:17:00 PM
Discovery Laboratories (DSCO) Reports Fourth Quarter 2014 Financial Results And Provides Update On SURFAXIN (lucinactant) Intratracheal Suspension And AEROSURF Program 3/17/2015 10:37:39 AM
12345678910...
//-->